© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
972589 |
As an accredited 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Few chemicals command both curiosity and respect in the synthetic chemistry world like 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide. As someone who’s spent countless hours peering through laboratory glassware, I’ve seen how small molecular changes ripple out into big differences down the line. This compound, built with a trifluoromethyl and a fluoro group on the aromatic ring, packs both volatility and specificity into a single package. It doesn’t just add another chapter to the saga of phenylacetic acid derivatives—it sets its own page apart with features chemists rely on for more efficient and targeted syntheses.
Let’s break down its anatomy a little. The backbone—a phenylacetic acid skeleton—offers a platform both sturdy and versatile. Swapping in a fluorine at position four and a trifluoromethyl at position three brings a unique electronic character. The key site here is the bromoacetyl group, a reactive moiety that brings possibilities. In terms of empirical formula, it checks in as C9H5BrF4O. Watching how it behaves under standard lab conditions gives insights into its stability profile: while sensitive to moisture, it has shown consistent performance in solvent systems favored by process chemists.
Structural modifications like adding a fluoro or trifluoromethyl group are not just theoretical exercises. They change polarity, tweak steric hindrance, and offer a way to drive selectivity in a world where byproducts can make or break a whole run. Many in the community appreciate how the bromide group in 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide brings a high leaving group ability, making it a choice candidate for nucleophilic substitution reactions without demanding extreme conditions.
My initial encounters with this molecule were always driven by need: seeking intermediates for pharmaceuticals or exploring agrochemical leads. In the real world, chemists often reach for 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide when they want to assemble fluorinated analogues. Fluorinated structures show up in the DNA of many modern drugs, partly due to their ability to increase metabolic stability and modulate binding profiles. Introducing a trifluoromethyl group, in particular, has become almost standard for dialing up potency or selectivity in new chemical entities.
No molecule operates in a vacuum. I’ve reached for this specific bromoacetyl compound in multi-step syntheses, largely because it responds predictably with amines and alcohols to give products that feature heavily in real-world pharmaceuticals. Peptide mimetics with enhanced stability, imaging agents that stand out in fluorine NMR, and active pharmaceutical ingredients (APIs) that require both fluorine substituents—all tend to have some connection to molecules like these during their earlier stages of development.
Certain crop protection agents also derive their performance from rings with heavy halogen substitution. For chemists focused on fine-tuning activity or soil stability, 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide steps into the toolbox right where others might fall short.
The chemist’s bench lives in the details. There are dozens of phenylacetyl bromide analogues. Once you introduce fluorine to the mix, things quickly change. Compared with its plainer relatives, the presence of both a fluoro and trifluoromethyl substitution doesn’t just catch the eye in a line-up—it really pops during synthesis. In practice, this means reactivity that’s neither sluggish nor uncontrollably frisky. Chemists often remark how the molecule’s electron-withdrawing nature brings a measured pace to reactions, favoring high selectivity and minimizing messy side Products.
On top of that, the molecular rigidity given by these electron-withdrawing groups often translates into more defined spectroscopic signatures. I’ve found that NMR and mass spec data for this compound tend to show less ambiguity compared to non-fluorinated analogs—which means less troubleshooting for the researcher and more confidence at the characterization stage. This specificity proves especially valuable in regulated environments, where analytical clarity keeps both processes and regulatory submissions running smoothly.
Back in graduate school, plenty of time got burned chasing down elusive intermediates, only to watch them fall apart during purification. With compounds like 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide, the planning becomes more efficient. Many value these types of reagents for their role in accessing molecules that sit at the crossroads of activity and stability.
Fluorinated aromatics aren’t just trendy—they have clear scientific underpinnings. A well-placed trifluoromethyl group doesn’t just make for a poster-worthy structure; it steps up pharmacokinetics, influences membrane permeability, and helps shield molecules against metabolic breakdown. These practical concerns drive the choice of reagents year after year.
It’s tempting to lump all substituted phenylacetic acid derivatives together. Once you’ve spent long days slogging through different reaction conditions, the differences become clear. Other bromide reagents might deliver decent conversions, yet ignore subtleties like electronic compatibility or downstream ease of derivatization. Compared with something like 3-fluorophenylacetyl bromide or para-substituted analogues, the molecule highlighted here carries both greater reactivity (due to the bromoacetyl) and more nuanced electronic tuning (thanks to the two separate fluorine-bearing groups). If the end goal lies in tuning biological activity, these details add up fast.
There’s also a growing recognition among bench chemists that greener processes start with smarter inputs. The efficient, targeted reactions enabled by 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide help avoid waste—not just as a talking point, but as a line item in real process optimization.
Consistency—the kind you can plan a month’s work around—matters more than having every analytic curve picture-perfect. Based on hands-on experience and field feedback, batches of this compound have shown solid reliability, holding up through transport and storage in typical laboratory environments as long as moisture is kept at bay. Researchers (myself included) value how a ‘tried and true’ phenylacetyl bromide derivative can shave hours off method development by providing expected, manageable reactivity.
At a time when reproducibility concerns gnaw at the edges of chemical science, compounds like 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide quietly build trust. The molecule’s behavior under standard conditions aligns with published data from many academic and industrial sources. Reproducibility doesn’t happen by accident—it grows out of structural predictability and stable supply chains.
Every chemist picks up a healthy respect for halogenated aromatics. With 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide, reasonable caution goes hand in hand with everyday lab use. Moisture-sensitive compounds present a real-world obstacle, yet sealed storage and simple desiccation take care of most common headaches. The molecule requires the usual protective steps—gloves, fume hood, and good chemical sense. Regular oversight and adherence to institutional protocols keep teams safe while working with these reagents.
Waste handling also gets easier with this compound compared to other, less stable or more reactive halogenated reagents. Clear guidance on disposal, coupled with the relatively high conversion efficiency, helps cut down on environmental concerns.
Nobody in chemistry ignores trends for long. Over the past decade, I’ve seen growing demand for specialty fluorinated intermediates—pharmaceuticals, agrochemicals, imaging agents, and more. As regulatory standards set tighter controls on impurities and downstream byproducts, chemists have become more selective in the reagents they reach for. The dual substitution pattern—bringing both a fluoro and a trifluoromethyl to the table—gives 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide a stable niche in an increasingly competitive field.
Scientists appreciate a molecule that doesn’t just fill a gap but actively advances research goals. For teams looking to synthesize building blocks that meet both traditional activity requirements and new toxicity standards, derivatives like this one make their way onto purchasing lists and then into routine lab use.
The world of fine chemicals moves forward on precision, both in synthesis and labeling. Over time, regulatory agencies have raised the bar for documentation and tracking, especially where halogenated compounds are concerned. 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide, by virtue of its structural features and predictable performance, often ticks the right boxes—purity profiles, analytical clarity, traceability.
Feedback from regulatory filings points to the value of clean analytical signatures and the minimized formation of unwanted byproducts. These benefits echo throughout research pipelines, making the day-to-day work of documentation less fraught with surprises. For supply teams and procurement specialists, this means easier communication with compliance officers, and for chemists, it removes hurdles during literature review and patent drafting.
In my own experience, regulators appreciate submissions that show careful planning from the reagent selection stage onward. 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide gives teams a running start in satisfying preclinical screening requirements, environmental assessments, and traceability reporting.
Every synthetic chemist has faced the uncertainty of a dodgy reagent. Reports circulated across professional networks usually flag which suppliers have shown consistency in their batches. For compounds like this, expectations set in the literature turn into real benchmarks in the lab. High-purity material, coupled with reassuring spectroscopic identities, helps squash anxiety about reaction surprises.
Many who have handled 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide firsthand note the repeatable signatures in NMR and mass spectrometry, especially with the distinct fluorine peaks and the impact of the trifluoromethyl group on chemical shift. In fast-moving research environments, this confidence becomes more than a convenience—it keeps teams on schedule and projects advancing.
Modern drug discovery values adaptiveness. As new therapeutic classes emerge—beyond just kinase inhibitors and immune modulators—chemists reach deeper into the toolbox. Incorporating fluorine into drug molecules isn’t just fashionable; it brings real changes to how those drugs behave in the human body. The emergence of multipurpose intermediates, like 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide, tracks closely with advances in medicinal chemistry.
Fluorinated building blocks offer new angles in tweaking ADME (absorption, distribution, metabolism, excretion), with direct impacts on efficacy, safety, and dosing schedules. Early-stage labs benefit from reagents that let them pivot between analog series without restarting route scouting from scratch.
From my perspective, nothing matches the sense of momentum in a lab when a new intermediate seamlessly replaces dozens of more cumbersome alternatives. Scientists, under pressure to meet both time and quality targets, take notice when a new reagent makes their jobs easier. Reports from collaborative research programs showcase the adoption of 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide in the generation of new phenylacetic acid derivatives—drugs developed for neurological, oncological, and infectious disease indications.
Every chemist reads the headlines about green chemistry and sustainable manufacturing. Having watched the field move over the decades, there’s a clear trend toward intermediates that lend themselves to low-waste, high-yield processes. Compounds like this fit the bill nicely: smart substitution patterns yield faster, more selective reactions, reducing the burden on purification and disposal.
Industry has started to view sustainable practice not just as a compliance box, but as a mark of leadership. The minimal waste generated from using highly selective reagents, combined with the environmental advantages of high conversion rates, plays well in both internal audits and external reporting. For a new generation of chemists coming up, reagents like 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide represent more than a means to an end; they signal a shift towards responsible, science-driven innovation.
Research is rarely static. The future will always hold novel fluorinated intermediates, more intricate building blocks, and challenges that push chemists to adapt. From where I stand, intermediates with dual or even multiple halogen substitutions will maintain a central place, driven by both scientific and practical needs.
The story of 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide isn’t just about clever molecular engineering; it’s about building bridges—between disciplines, between research goals, between regulatory tapestries. As teams continue to develop more advanced therapies and sustainable materials, the demand for reagents that blend reliability, reactivity, and safety will only keep growing.
Having watched this compound become part of everyday lab talk and seeing the results in fine chemical pipelines, there’s no doubt of its staying power. R&D groups will keep building on its foundation, supported by both old hands who remember the hard days of inconsistent intermediates and by the future generation focused on pushing chemistry into smarter, more responsible territory.
The best advances come from listening to what hasn’t worked. Researchers, in my circle and beyond, highlight a few persistent themes: the need for better supply reliability, clearer documentation, and continued education about safe handling of reactive halides. Building strong supplier relationships pays off—consistency in raw material prevents lost months down the line. At the bench level, regular safety briefings keep even experienced hands alert to the handling and storage considerations unique to halogenated reagents. Process improvements, such as automation or enhanced real-time monitoring, further reduce uncertainty.
Collaborative networks of chemists—from academia to large-scale manufacturing—help refine best practices. Many labs now share both troubleshooting tips and small protocol tweaks that can mean the difference between a near-miss incident and a routine day at the bench. By focusing on incremental gains—better storage, standardized purity documentation, sharing analytical techniques—chemists elevate the whole field alongside the molecules they make.
Open access to analytical data, application notes, and continuous supplier engagement will only grow in value. Whether designing a new synthetic path or optimizing an old one, input from colleagues makes each step safer and more efficient. Halogenated intermediates like 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide are not just reagents—they’re links in a global chain, each connection strengthened by shared knowledge.
Too often, chemicals appear in catalogs as a string of syllables, stripped of all the experience and judgement that bring them to life in the lab. What distinguishes 4-Fluoro-3-Trifluoromethylphenylacetyl Bromide, from my perspective, is that it doesn’t just slot into existing workflows—it strives to improve them. For chemists looking for new ways to tackle tough challenges, understanding what sets a reagent apart, how it functions day to day, and how it impacts the broader research landscape matters more than ever.
Working with this molecule isn’t just about mixing the right solvents or timing the reaction. It’s about building on what works, improving what doesn’t, and taking seriously the trust other scientists place in every batch, every experiment, every downstream application. In a world where both opportunities and scrutiny keep rising, compounds with demonstrated value—rooted in facts, field experience, and an eye toward the future—will always find a welcome place at the heart of progress.
